Moreaux et al demonstrated that CD200 mRNA is overexpressed on cells of several types of cancers compared to their normal counterparts, including chronic lymphocytic leukemia (CLL) (19). Here, CD200 is linked to B-cell chronic lymphocytic leukemia.